American Society of Hematology

ASH is the leader in representing the interests of scientists and clinicians working in the field of hematology on Capitol Hill and within federal agencies concerned with the study and treatment of blood-related diseases.

  • Take Action to Protect Medical and Public Health Research

    In July, the Senate Appropriations Committee approved a draft spending bill that would provide nearly $31 billion for the National Institutes of Health (NIH) in fiscal year (FY) 2014, an amount that would replace funding lost due to sequestration and provide a small increase over the FY 2012 NIH budget.

  • Urge Congress to Pass the SGR Repeal and Medicare Provider Payment Modernization Act and Provide Stable Medicare Physician Payments

    On February 6, 2014 the leadership of the House Ways and Means and Energy and Commerce Committees and the Senate Finance Committee released a bi-partisan and bicameral bill to repeal the Sustainable Growth Rate (SGR) formula that has driven annual reductions in Medicare payment for physician services. Your advocacy is needed to ensure that the legislation can be considered by the full House of Representatives and Senate before the short-term physician fee update expires on April 1, 2014.

View all action alerts
  • Ebola Alert

    The Department of Health and Human Services' Centers for Disease Control and Prevention (CDC) and Office of the Assistant Secretary for Preparedness and Response (ASPR) continues to respond to the current Ebola outbreak in West Africa. The CDC has summarized key messages about the outbreak and the response, and it will continue to update its resources as more information becomes available.

  • Sunshine Data Released – What’s Next?

    On September 30 at around 2PM, the Centers for Medicare and Medicaid Services (CMS) publicly released the data that it had been gathering from pharmaceutical and medical device companies that detail value transfers to physicians and medical schools.  ASH has been keeping members apprised of these developments since this provision was included in the Affordable Care Act.

  • Least Costly Alternatives for Drugs in the World of Hematology

    The Medicare Payment Advisory Commission (MedPAC) used its second session of the 2014-2015 cycle to take on an issue that could be very important for hematologists and access to drugs for their patients–the opportunity for Medicare to pay for drugs on a “least costly alternative” basis.  ASH continues to follow this issue as part of a commitment to ensure that policies are created that give patients efficient access to important drugs while maintaining clinician decision-making and incentives for continued innovation.

  • Medicaid Pay Parity Nears Expiration – ASH Works with ACP to Extend

    Since the passage of the ACA, specialists in internal medicine—including hematologists—have been eligible for increased Medicaid payment rates. The ACA, however, limited this increase in payment to 2013 and 1014, and the rates will soon revert to their former levels without further legislation. ASH has worked with the American College of Physicians and other stakeholders to support legislation that would extend this payment parity, and has recently submitted a letter to further show support.

View all policy news
back to top